Julie Olsson

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Nicola A. Hanania, Phillip E. Korenblat, Kenneth R. Chapman et al. · The Lancet Respiratory Medicine · 2016 · 466 citations

Medicine, Internal Medicine, Pharmacology +10

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Nicola A. Hanania, Michael Noonan, Jonathan Corren et al. · Thorax · 2015 · 377 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report

Timothy S. Blackwell, Andrew M. Tager, Zea Borok et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 247 citations

Veterinary Medicine, Molecular Biology, Pathobiology +17

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

Iván O. Rosas, George Diaz, Robert Gottlieb et al. · Intensive Care Medicine · 2021 · 124 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Timeliness of Care in Veterans With Non-small Cell Lung Cancer

Michael K. Gould, Sharfun Ghaus, Julie Olsson et al. · CHEST Journal · 2008 · 83 citations

Medicine, Oncology, Palliative Care +6